ClinicalTrials.gov record
Dose Range Finding Study of Fedovapagon in Men With Nocturia
ClinicalTrials.gov ID: NCT01656239
Public ClinicalTrials.gov record NCT01656239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Dose Range Finding Study To Determine The Efficacy And Safety Of Fedovapagon In Men With Nocturia
Study identification
- NCT ID
- NCT01656239
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vantia Ltd
- Industry
- Enrollment
- 358 participants
Conditions and interventions
Conditions
Interventions
- fedovapagon 1 mg Drug
- fedovapagon 2 mg Drug
- fedovapagon 4 mg Drug
- Placebo ( sugar pill) Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2012
- Primary completion
- Jul 31, 2013
- Completion
- Aug 31, 2013
- Last update posted
- Jun 19, 2014
2012 – 2013
United States locations
- U.S. sites
- 56
- U.S. states
- 30
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vantia Investigative Center | Birmingham | Alabama | — | — |
| Vantia Investigative Center | Huntsville | Alabama | — | — |
| Vantia Investigative Center | Mobile | Alabama | — | — |
| Vantia Investigative Center | Glendale | Arizona | — | — |
| Vantia Investigative Center | Tucson | Arizona | — | — |
| Vantia Investigative Center | Anaheim | California | — | — |
| Vantia Investigative Center | Long Beach | California | — | — |
| Vantia Investigative Center | San Diego | California | — | — |
| Vantia Investigative Center | Denver | Colorado | — | — |
| Vantia Investigative Center | Englewood | Colorado | — | — |
| Vantia Investigative Center | Milford | Connecticut | — | — |
| Vantia Investigative Center | Aventura | Florida | — | — |
| Vantia Investigative Center | Clearwater | Florida | — | — |
| Vantia Investigative Center | Daytona Beach | Florida | — | — |
| Vantia Investigative Center | DeLand | Florida | — | — |
| Vantia Investigative Center | Naples | Florida | — | — |
| Vantia Investigative Center | Ocala | Florida | — | — |
| Vantia Investigative Center | St. Petersburg | Florida | — | — |
| Vantia Investigative Center | Tampa | Florida | — | — |
| Vantia Investigative Center | Coeur d'Alene | Idaho | — | — |
| Vantia Investigative Center | Meridian | Idaho | — | — |
| Vantia Investigative Center | Chicago | Illinois | — | — |
| Vantia Investigative Center | Evansville | Indiana | — | — |
| Vantia Investigative Center | Jeffersonville | Indiana | — | — |
| Vantia Investigative Center | Paducah | Kentucky | — | — |
| Vantia Investigative Center | Metairie | Louisiana | — | — |
| Vantia Investigative Center | Greenbelt | Maryland | — | — |
| Vantia Investigative Center | Rochester | Michigan | — | — |
| Vantia Investigative Center | Edina | Minnesota | — | — |
| Vantia Investigative Center | Omaha | Nebraska | — | — |
| Vantia Investigative Center | Brick | New Jersey | — | — |
| Vantia Investigative Center | Englewood | New Jersey | — | — |
| Vantia Investigative Center | Lawrenceville | New Jersey | — | — |
| Vantia Investigative Center | Albuquerque | New Mexico | — | — |
| Vantia Investigative Center | Brooklyn | New York | — | — |
| Vantia Investigative Center | Endwell | New York | — | — |
| Vantia Investigative Center | Garden City | New York | — | — |
| Vantia Investigative Center | New York | New York | — | — |
| Vantia Investigative Center | Poughkeepsie | New York | — | — |
| Vantia Investigative Center | Concord | North Carolina | — | — |
| Vantia Investigative Center | Raleigh | North Carolina | — | — |
| Vantia Investigative Center | Winston-Salem | North Carolina | — | — |
| Vantia Investigative Center | Cincinnati | Ohio | — | — |
| Vantia Investigative Center | Bethany | Oklahoma | — | — |
| Vantia Investigative Center | Bala-Cynwyd | Pennsylvania | — | — |
| Vantia Investigative Center | Warwick | Rhode Island | — | — |
| Vantia Investigative Center | Mytrle Beach | South Carolina | — | — |
| Vantia Investigative Center | Dakota Dunes | South Dakota | — | — |
| Vantia Investigative Center | Nashville | Tennessee | — | — |
| Vantia Investigative Center | Dallas | Texas | — | — |
| Vantia Investigative Center | Fort Worth | Texas | — | — |
| Vantia Investigative Center | San Antonio | Texas | — | — |
| Vantia Investigative Center | Richmond | Virginia | — | — |
| Vantia Investigative Center | Virginia Beach | Virginia | — | — |
| Vantia Investigative Center | Burien | Washington | — | — |
| Vantia Investigative Center | Middleton | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01656239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 19, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01656239 live on ClinicalTrials.gov.